Avantor Q2 results beat, raises 2026 outlook
AVTR•Key quarterly figures
| Metric | Actual | Consensus |
|---|---|---|
| Q2 sales | $1.69 billion | $1.61 billion |
| Q2 adjusted EPS | $0.21 | $0.19 |
| Q2 net income | $38.10 million | |
| Q2 gross profit | $537 million | |
| Q2 operating income | $121.80 million | |
| Q2 pretax profit | $81.20 million |
Q2 results beat expectations
Avantor, a life science tools provider, said second-quarter sales rose 0.5% and beat analyst expectations.
Adjusted earnings per share for the quarter were $0.21, above analyst consensus.
Management comments on performance
CEO Emmanuel Ligner said the company's Revival program improved customer service and business performance.
He also said the segment returned to positive organic revenue growth sooner than expected.
